Massachusetts drug developer pSivida is ready to move its latest eye drug/device combo to the next stage now that Phase III results show overwhelming efficacy.
The results from a late-stage study of Medidur were announced on Dec. 22, showing the implant was more effective than...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?